Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 215

1.

A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy.

Takahara M, Nagato T, Nozaki Y, Kumai T, Katada A, Hayashi T, Harabuchi Y.

Cell Immunol. 2019 May 8:103925. doi: 10.1016/j.cellimm.2019.103925. [Epub ahead of print]

PMID:
31088610
2.

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress.

Harabuchi Y, Takahara M, Kishibe K, Nagato T, Kumai T.

Front Pediatr. 2019 Apr 16;7:141. doi: 10.3389/fped.2019.00141. eCollection 2019. Review.

3.
4.

Subglottic Stenosis in Granulomatosis With Polyangiitis.

Nagato T, Kishibe K, Harabuchi Y.

Am J Med Sci. 2019 Apr;357(4):e13-e14. doi: 10.1016/j.amjms.2019.01.005. Epub 2019 Jan 12. No abstract available.

PMID:
30904050
5.

On Benchmarking of Automated Methods for Performing Exhaustive Reaction Path Search.

Maeda S, Harabuchi Y.

J Chem Theory Comput. 2019 Apr 9;15(4):2111-2115. doi: 10.1021/acs.jctc.8b01182. Epub 2019 Mar 18.

PMID:
30860828
6.

Novel compound heterozygous CDH23 variants in a patient with Usher syndrome type I.

Okano S, Makita Y, Katada A, Harabuchi Y, Kohmoto T, Naruto T, Masuda K, Imoto I.

Hum Genome Var. 2019 Jan 28;6:8. doi: 10.1038/s41439-019-0037-y. eCollection 2019.

7.

Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma.

Nagato T, Ueda S, Takahara M, Kishibe K, Komabayashi Y, Kumai T, Ohara K, Hirata-Nozaki Y, Harabuchi S, Hayashi R, Ohkuri T, Bernasconi M, Nadal D, Kobayashi H, Harabuchi Y.

Lab Invest. 2019 May;99(5):612-624. doi: 10.1038/s41374-018-0182-9. Epub 2019 Jan 21.

PMID:
30664711
8.

Targeted next-generation sequencing of cancer-related genes in thyroid carcinoma: A single institution's experience.

Bandoh N, Akahane T, Goto T, Kono M, Ichikawa H, Sawada T, Yamaguchi T, Nakano H, Kawase Y, Kato Y, Kamada H, Harabuchi Y, Shimizu K, Nishihara H.

Oncol Lett. 2018 Dec;16(6):7278-7286. doi: 10.3892/ol.2018.9538. Epub 2018 Oct 2.

9.

Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma.

Ohara K, Ohkuri T, Kumai T, Nagato T, Nozaki Y, Ishibashi K, Kosaka A, Nagata M, Harabuchi S, Ohara M, Oikawa K, Aoki N, Harabuchi Y, Celis E, Kobayashi H.

Oncoimmunology. 2018 Aug 1;7(9):e1466771. doi: 10.1080/2162402X.2018.1466771. eCollection 2018.

PMID:
30510853
10.

Femtosecond electronic relaxation and real-time vibrational dynamics in 2'-hydroxychalcone.

Yamakita Y, Yokoyama N, Xue B, Shiokawa N, Harabuchi Y, Maeda S, Kobayashi T.

Phys Chem Chem Phys. 2019 Mar 6;21(10):5344-5358. doi: 10.1039/c8cp06405a.

PMID:
30484793
11.

Excited-State Reactivity of [Mn(im)(CO)3 (phen)]+ : A Structural Exploration.

Fumanal M, Harabuchi Y, Gindensperger E, Maeda S, Daniel C.

J Comput Chem. 2019 Jan 5;40(1):72-81. doi: 10.1002/jcc.25535. Epub 2018 Sep 12.

PMID:
30277592
12.

Glomangiopericytoma of the Nasal Cavity with CTNNB1 p.S37C Mutation: A Case Report and Literature Review.

Kono M, Bandoh N, Matsuoka R, Goto T, Akahane T, Kato Y, Nakano H, Yamaguchi T, Harabuchi Y, Nishihara H.

Head Neck Pathol. 2018 Sep 11. doi: 10.1007/s12105-018-0961-z. [Epub ahead of print]

PMID:
30206803
13.

Exploring potential crossing seams in periodic systems: Intersystem crossing pathways in the benzene crystal.

Saita K, Takagi M, Harabuchi Y, Okada H, Maeda S.

J Chem Phys. 2018 Aug 21;149(7):072329. doi: 10.1063/1.5025023.

PMID:
30134685
14.

Cochlear implantation in patients with bilateral deafness caused by otitis media with ANCA-associated vasculitis (OMAAV): A report of four cases.

Watanabe T, Yoshida H, Kishibe K, Morita Y, Yoshida N, Takahashi H, Harabuchi Y.

Auris Nasus Larynx. 2018 Oct;45(5):922-928. doi: 10.1016/j.anl.2017.12.007. Epub 2018 May 25.

PMID:
29807863
15.

Treatment outcome and prognostic factors of tonsillectomy for palmoplantar pustulosis and pustulotic arthro-osteitis: A retrospective subjective and objective quantitative analysis of 138 patients.

Takahara M, Hirata Y, Nagato T, Kishibe K, Katada A, Hayashi T, Kishibe M, Ishida-Yamamoto A, Harabuchi Y.

J Dermatol. 2018 Jul;45(7):812-823. doi: 10.1111/1346-8138.14348. Epub 2018 May 6.

PMID:
29732605
16.

Different photoisomerization routes found in the structural isomers of hydroxy methylcinnamate.

Kinoshita SN, Miyazaki Y, Sumida M, Onitsuka Y, Kohguchi H, Inokuchi Y, Akai N, Shiraogawa T, Ehara M, Yamazaki K, Harabuchi Y, Maeda S, Taketsugu T, Ebata T.

Phys Chem Chem Phys. 2018 Jul 4;20(26):17583-17598. doi: 10.1039/c8cp00414e.

PMID:
29693100
17.

Sustained Persistence of IL2 Signaling Enhances the Antitumor Effect of Peptide Vaccines through T-cell Expansion and Preventing PD-1 Inhibition.

Sultan H, Kumai T, Fesenkova VI, Fan AE, Wu J, Cho HI, Kobayashi H, Harabuchi Y, Celis E.

Cancer Immunol Res. 2018 May;6(5):617-627. doi: 10.1158/2326-6066.CIR-17-0549. Epub 2018 Feb 26.

18.

Exploring radiative and nonradiative decay paths in indole, isoindole, quinoline, and isoquinoline.

Harabuchi Y, Saita K, Maeda S.

Photochem Photobiol Sci. 2018 Mar 14;17(3):315-322. doi: 10.1039/c7pp00385d.

PMID:
29360113
19.

Analyses of trajectory on-the-fly based on the global reaction route map.

Tsutsumi T, Harabuchi Y, Ono Y, Maeda S, Taketsugu T.

Phys Chem Chem Phys. 2018 Jan 17;20(3):1364-1372. doi: 10.1039/c7cp06528k.

PMID:
29260170
20.

Implementation and performance of the artificial force induced reaction method in the GRRM17 program.

Maeda S, Harabuchi Y, Takagi M, Saita K, Suzuki K, Ichino T, Sumiya Y, Sugiyama K, Ono Y.

J Comput Chem. 2018 Feb 5;39(4):233-251. doi: 10.1002/jcc.25106. Epub 2017 Nov 14.

21.

Cancer immunotherapy: moving forward with peptide T cell vaccines.

Kumai T, Fan A, Harabuchi Y, Celis E.

Curr Opin Immunol. 2017 Aug;47:57-63. doi: 10.1016/j.coi.2017.07.003. Epub 2017 Jul 19. Review.

22.

A novel strategy with combined assays for detection of anti-neutrophil cytoplasmic antibody (ANCA) in clinically ANCA-negative granulomatosis with polyangiitis patients.

Tateyama K, Kodama S, Kishibe K, Harabuchi Y, Suzuki M.

Auris Nasus Larynx. 2017 Dec;44(6):735-741. doi: 10.1016/j.anl.2017.03.002. Epub 2017 Jun 27.

PMID:
28666565
23.

Intratumoral injection of IFN-β induces chemokine production in melanoma and augments the therapeutic efficacy of anti-PD-L1 mAb.

Uehara J, Ohkuri T, Kosaka A, Ishibashi K, Hirata Y, Ohara K, Nagato T, Oikawa K, Aoki N, Harabuchi Y, Ishida-Yamamoto A, Kobayashi H.

Biochem Biophys Res Commun. 2017 Aug 19;490(2):521-527. doi: 10.1016/j.bbrc.2017.06.072. Epub 2017 Jun 15.

PMID:
28624449
24.

Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy.

Nagato T, Ohkuri T, Ohara K, Hirata Y, Kishibe K, Komabayashi Y, Ueda S, Takahara M, Kumai T, Ishibashi K, Kosaka A, Aoki N, Oikawa K, Uno Y, Akiyama N, Sado M, Takei H, Celis E, Harabuchi Y, Kobayashi H.

Cancer Immunol Immunother. 2017 Jul;66(7):877-890. doi: 10.1007/s00262-017-1987-x. Epub 2017 Mar 27.

PMID:
28349165
25.

Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site.

Ohkuri T, Kosaka A, Ishibashi K, Kumai T, Hirata Y, Ohara K, Nagato T, Oikawa K, Aoki N, Harabuchi Y, Celis E, Kobayashi H.

Cancer Immunol Immunother. 2017 Jun;66(6):705-716. doi: 10.1007/s00262-017-1975-1. Epub 2017 Feb 27.

PMID:
28243692
26.

Up-regulation of CX3CR1 on tonsillar CD8-positive cells in patients with IgA nephropathy.

Otaka R, Takahara M, Ueda S, Nagato T, Kishibe K, Nomura K, Katada A, Hayashi T, Harabuchi Y.

Hum Immunol. 2017 Apr;78(4):375-383. doi: 10.1016/j.humimm.2017.02.004. Epub 2017 Feb 11.

PMID:
28196748
27.

ANCA-Negative Granulomatosis with Polyangiitis Presenting with Hypertrophic Cranial Pachymeningitis, Abducens Nerve Palsy, and Stenosis of the Internal Carotid Artery.

Harabuchi S, Bandoh N, Yasukawa R, Kono M, Goto T, Harabuchi Y, Ikeda H, Kamada H, Nishihara H.

Case Rep Otolaryngol. 2017;2017:9687383. doi: 10.1155/2017/9687383. Epub 2017 Nov 30.

28.

Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses.

Kumai T, Lee S, Cho HI, Sultan H, Kobayashi H, Harabuchi Y, Celis E.

Cancer Immunol Res. 2017 Jan;5(1):72-83. doi: 10.1158/2326-6066.CIR-16-0194. Epub 2016 Dec 9.

29.

Peptide vaccines in cancer-old concept revisited.

Kumai T, Kobayashi H, Harabuchi Y, Celis E.

Curr Opin Immunol. 2017 Apr;45:1-7. doi: 10.1016/j.coi.2016.11.001. Epub 2016 Dec 9. Review.

30.

Randomized controlled trial of juzen-taiho-to in children with recurrent acute otitis media.

Ito M, Maruyama Y, Kitamura K, Kobayashi T, Takahashi H, Yamanaka N, Harabuchi Y, Origasa H, Yoshizaki T.

Auris Nasus Larynx. 2017 Aug;44(4):390-397. doi: 10.1016/j.anl.2016.10.002. Epub 2016 Oct 31.

PMID:
27810126
31.

Ab Initio Molecular Dynamics Study of the Photoreaction of 1,1'-Dimethylstilbene upon S0 → S1 Excitation.

Harabuchi Y, Yamamoto R, Maeda S, Takeuchi S, Tahara T, Taketsugu T.

J Phys Chem A. 2016 Nov 10;120(44):8804-8812. Epub 2016 Nov 1.

PMID:
27766873
32.

Artificial Force Induced Reaction (AFIR) Method for Exploring Quantum Chemical Potential Energy Surfaces.

Maeda S, Harabuchi Y, Takagi M, Taketsugu T, Morokuma K.

Chem Rec. 2016 Oct;16(5):2232-2248. doi: 10.1002/tcr.201600043. Epub 2016 Jun 3.

PMID:
27258568
33.

Structural dynamics of photochemical reactions probed by time-resolved photoelectron spectroscopy using high harmonic pulses.

Iikubo R, Sekikawa T, Harabuchi Y, Taketsugu T.

Faraday Discuss. 2016 Dec 16;194:147-160. doi: 10.1039/c6fd00063k.

PMID:
27711881
34.

Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer/T-cell lymphoma.

Komabayashi Y, Kishibe K, Nagato T, Ueda S, Takahara M, Harabuchi Y.

Hematol Oncol. 2017 Dec;35(4):655-663. doi: 10.1002/hon.2360. Epub 2016 Oct 6.

PMID:
27709652
35.

Multistep Intersystem Crossing Pathways in Cinnamate-Based UV-B Sunscreens.

Yamazaki K, Miyazaki Y, Harabuchi Y, Taketsugu T, Maeda S, Inokuchi Y, Kinoshita SN, Sumida M, Onitsuka Y, Kohguchi H, Ehara M, Ebata T.

J Phys Chem Lett. 2016 Oct 6;7(19):4001-4007. Epub 2016 Sep 28.

PMID:
27657500
36.

Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy.

Ishibashi K, Kumai T, Ohkuri T, Kosaka A, Nagato T, Hirata Y, Ohara K, Oikawa K, Aoki N, Akiyama N, Sado M, Kitada M, Harabuchi Y, Celis E, Kobayashi H.

Oncoimmunology. 2016 Mar 30;5(6):e1169356. doi: 10.1080/2162402X.2016.1169356. eCollection 2016 Jun.

37.

Theoretical study on mechanism of the photochemical ligand substitution of fac-[Re(I)(bpy)(CO)3(PR3)](+) complex.

Saita K, Harabuchi Y, Taketsugu T, Ishitani O, Maeda S.

Phys Chem Chem Phys. 2016 Jul 14;18(26):17557-64. doi: 10.1039/c6cp02314b. Epub 2016 Jun 16.

PMID:
27306043
38.

Carcinoma ex pleomorphic adenoma of the parotid gland: a multi-institutional retrospective analysis in the Northern Japan Head and Neck Cancer Society.

Suzuki M, Matsuzuka T, Saijo S, Takahara M, Harabuchi Y, Okuni T, Himi T, Kakizaki T, Fukuda S, Yamada K, Nagahashi T, Abe T, Shinkawa H, Katagiri K, Sato H, Fukui N, Ishikawa K, Suzuki T, Kobayashi T, Saito D, Saijo S, Tateda M, Hashimoto S, Ishida A, Kakehata S, Suzuki O, Hashimoto Y, Omori K.

Acta Otolaryngol. 2016 Nov;136(11):1154-1158. Epub 2016 Jun 13.

PMID:
27295405
39.

Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): A retrospective analysis of 235 patients from a nationwide survey in Japan.

Harabuchi Y, Kishibe K, Tateyama K, Morita Y, Yoshida N, Kunimoto Y, Matsui T, Sakaguchi H, Okada M, Watanabe T, Inagaki A, Kobayashi S, Iino Y, Murakami S, Takahashi H, Tono T.

Mod Rheumatol. 2017 Jan;27(1):87-94. doi: 10.1080/14397595.2016.1177926. Epub 2016 May 11.

PMID:
27166750
40.

Evidence-based clinical practice guidelines for IgA nephropathy 2014.

Yuzawa Y, Yamamoto R, Takahashi K, Katafuchi R, Tomita M, Fujigaki Y, Kitamura H, Goto M, Yasuda T, Sato M, Urushihara M, Kondo S, Kagami S, Yasuda Y, Komatsu H, Takahara M, Harabuchi Y, Kimura K, Matsuo S.

Clin Exp Nephrol. 2016 Aug;20(4):511-535. doi: 10.1007/s10157-015-1223-y. No abstract available.

41.

Exploring the Mechanism of Ultrafast Intersystem Crossing in Rhenium(I) Carbonyl Bipyridine Halide Complexes: Key Vibrational Modes and Spin-Vibronic Quantum Dynamics.

Harabuchi Y, Eng J, Gindensperger E, Taketsugu T, Maeda S, Daniel C.

J Chem Theory Comput. 2016 May 10;12(5):2335-45. doi: 10.1021/acs.jctc.6b00080. Epub 2016 Apr 20.

PMID:
27045949
42.

Diagnostic value of liquid-based cytology with fine needle aspiration specimens for cervical lymphadenopathy.

Bandoh N, Goto T, Akahane T, Ohnuki N, Yamaguchi T, Kamada H, Harabuchi Y, Tanaka S, Nishihara H.

Diagn Cytopathol. 2016 Mar;44(3):169-76. doi: 10.1002/dc.23402. Epub 2016 Jan 9.

43.

Contrasting ring-opening propensities in UV-excited α-pyrone and coumarin.

Murdock D, Ingle RA, Sazanovich IV, Clark IP, Harabuchi Y, Taketsugu T, Maeda S, Orr-Ewing AJ, Ashfold MN.

Phys Chem Chem Phys. 2016 Jan 28;18(4):2629-38. doi: 10.1039/c5cp06597f.

PMID:
26701669
44.

Novel targets for natural killer/T-cell lymphoma immunotherapy.

Kumai T, Kobayashi H, Harabuchi Y.

Immunotherapy. 2016;8(1):45-55. doi: 10.2217/imt.15.103. Epub 2015 Dec 7. Review.

PMID:
26642249
45.

[Serological Study of Otitis Media with ANCA Associated Vasculitis (OMAAV)].

Tateyama K, Kodama S, Nomi N, Suzuki M, Kishibe K, Harabuchi Y.

Nihon Jibiinkoka Gakkai Kaiho. 2015 Sep;118(9):1133-42. Japanese.

PMID:
26615664
46.

Novel treatment for early-stage nasal natural killer/T-cell lymphoma: intra-maxillary arterial infusion chemotherapy with concomitant radiotherapy.

Takahara M, Nagato T, Kishibe K, Ueda S, Komabayashi Y, Yamashina M, Takahashi K, Harabuchi Y.

Hematol Oncol. 2017 Jun;35(2):158-162. doi: 10.1002/hon.2273. Epub 2015 Nov 13.

PMID:
26563973
47.
48.

Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma.

Kumai T, Ohkuri T, Nagato T, Matsuda Y, Oikawa K, Aoki N, Kimura S, Celis E, Harabuchi Y, Kobayashi H.

Sci Rep. 2015 Nov 5;5:16280. doi: 10.1038/srep16280.

49.

Nontotally symmetric trifurcation of an SN 2 reaction pathway.

Harabuchi Y, Ono Y, Maeda S, Taketsugu T, Keipert K, Gordon MS.

J Comput Chem. 2016 Feb 15;37(5):487-93. doi: 10.1002/jcc.24241. Epub 2015 Oct 29.

PMID:
26511597
50.

Supplemental Content

Loading ...
Support Center